On 29 July, KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO), announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug (IND) application for KB003, an anti-GM-CSF monoclonal antibody (mAb), in patients with chronic myelomonocytic leukemia (CMML), and that the IND is now active. KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) belongs to Healthcare sector. Its weekly performance is -10.95%. On last trading day company shares ended up $1.87. KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) distance from 50-day simple moving average (SMA50) is 52.80%.
TheStreet upgraded shares of Pendrell Corp (NASDAQ:PCO) from a sell rating to a hold rating in a research note released on Thursday morning. Pendrell Corporation (NASDAQ:PCO) shares moved up 11.27% in last trading session and ended the day at $1.58. PCO Gross Margin is 67.90% and its return on assets is -16.60%. Pendrell Corporation (NASDAQ:PCO) quarterly performance is 62.17%.
AngioDynamics (NASDAQ:ANGO), announce the enrollment of the first patient into the Registry of AngioVac Procedures In Detail (RAPID) Database at University of California-Los Angeles (UCLA) Health in Los Angeles, California.On 07 August, AngioDynamics Inc. (NASDAQ:ANGO) shares moved down -3.08% and was closed at $15.42. ANGO EPS growth in last 5 year was -27.90%. AngioDynamics Inc. (NASDAQ:ANGO) year to date (YTD) performance is -18.88%.
On 3 August, Constellation Brands (NYSE: STZ), announced that it has completed the acquisition of the Meiomi luxury wine brand. The transaction includes the Meiomi trademark and related inventories of pinot noir and chardonnay. Constellation Brands Inc. (NYSE:STZ) ended the last trading day at $123.53. Company weekly volatility is calculated as 1.08% and price to cash ratio as 184.60. Constellation Brands Inc. (NYSE:STZ) showed a weekly performance of 2.92%.
On 5 August, Questar Corporation(NYSE:STR) reported second-quarter 2015 net income of $40.6 million, or $0.23 per diluted share compared to second-quarter 2014 net income of $40.3 million, or $0.23 per diluted share. Adjusted earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) for the quarter were down 5% to $130.1 million compared to $137.3 million in the year-ago period. Questar Corporation (NYSE:STR) shares moved up 2.21% in last trading session and ended the day at $21.26. STR Gross Margin is 85.40% and its return on assets is 5.50%. Questar Corporation (NYSE:STR) quarterly performance is -7.17%.